Preliminary safety and efficacy results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Herzog, TJ; Spirtos, NM; Hines, JF; Braly, PS; Bell, M; Secord, AA; Rose, P; Monk, BJ; Soltes-Rak, E; Childs, BH

Published Date

  • June 20, 2007

Published In

Volume / Issue

  • 25 / 18

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X